- Home
- ITP vs XRTX Comparison
ITP vs XRTX Comparison
Compare ITP & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITP
- XRTX
- Stock Information
- Founded
- ITP 1996
- XRTX 2011
- Country
- ITP China
- XRTX Canada
- Employees
- ITP N/A
- XRTX N/A
- Industry
- ITP Paper
- XRTX Pharmaceuticals and Biotechnology
- Sector
- ITP Basic Materials
- XRTX Health Care
- Exchange
- ITP Nasdaq
- XRTX Nasdaq
- Market Cap
- ITP 4.5M
- XRTX 4.1M
- IPO Year
- ITP N/A
- XRTX N/A
- Fundamental
- Price
- ITP $0.43
- XRTX $1.00
- Analyst Decision
- ITP
- XRTX
- Analyst Count
- ITP 0
- XRTX 0
- Target Price
- ITP N/A
- XRTX N/A
- AVG Volume (30 Days)
- ITP 8.7M
- XRTX 278.9K
- Earning Date
- ITP 11-15-2024
- XRTX 11-15-2024
- Dividend Yield
- ITP N/A
- XRTX N/A
- EPS Growth
- ITP N/A
- XRTX N/A
- EPS
- ITP N/A
- XRTX N/A
- Revenue
- ITP $79,159,728.00
- XRTX N/A
- Revenue This Year
- ITP N/A
- XRTX N/A
- Revenue Next Year
- ITP N/A
- XRTX N/A
- P/E Ratio
- ITP N/A
- XRTX N/A
- Revenue Growth
- ITP N/A
- XRTX N/A
- 52 Week Low
- ITP $0.20
- XRTX $0.85
- 52 Week High
- ITP $1.07
- XRTX $7.00
- Technical
- Relative Strength Index (RSI)
- ITP 57.10
- XRTX 36.68
- Support Level
- ITP $0.41
- XRTX $0.85
- Resistance Level
- ITP $0.48
- XRTX $1.79
- Average True Range (ATR)
- ITP 0.11
- XRTX 0.19
- MACD
- ITP -0.00
- XRTX -0.01
- Stochastic Oscillator
- ITP 23.82
- XRTX 15.76
About ITP IT Tech Packaging Inc.
IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It involves in production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments Dongfang Paper and Tengsheng Paper, which produces offset printing paper, corrugating medium paper and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.